Phase II trial

Bionomics to Conduct Phase II Trial For Cancer Treatment in Australia

Bionomics has announced its plans to conduct a Phase II clinical trial of its BNC105 anti-cancer drug on 60 mesothelioma patients, at up to twelve centers in Australia. The company has contracted the Australasian Lung Cancer Trials Group (ALTG) a…

Phase II trial | 16 December 2009

• Bionomics
• BNC105
• cancer

ViroMed Receives Approval of Phase II Trial for Peripheral Artery Disease Drug

ViroMed has announced that VM202-PAD, a Deoxyribonucleic Acid (DNA) medicine for the treatment of Peripheral Artery Disease (PAD), has received approval from the US Food and Drug Administration (FDA) for a Phase II clinical trial. The trial will be p…

Phase II trial | 24 July 2009

• clinical
• trial
• fda
• VM202-PAD
• Peripheral
• Artery
• Disease

CanBas and Takeda Advance Cancer Drug into Phase II Trial

CanBas and Takeda Pharmaceutical Company have announced the advancement of CBP501 into Phase II clinical trials for the treatment of patients with non-small cell lung cancer (NSCLC). Current pre-clinical data suggest that the drug has the potential t…

Phase II trial | 23 July 2009

• CanBas
• Takeda
• CBP501
• clinical
• trial
• lung

Celtic Pharma Announces Successful Phase II Trial For Onychomycosis

Celtic Pharmaceutical Holdings has announced the successful outcome of its Phase II trial of TDT-067, terbinafine in Transfersomes, for the treatment of onychomycosis. The clinical trial treated patients for 12 weeks with a primary endpoint of m…

Phase II trial | 01 May 2009

Sosei Completes Phase II Trial Of AD 337 In Fibromyalgia Syndrome

Tokyo-based Sosei Group Corporation said AD 337, an enantiomer of an approved, centrally acting, non-opioid, analgesic, has completed a Phase II proof of principle trial for the treatment of fibromyalgia syndrome (FMS). The trial, a multi-centre,…

Phase II trial | 24 September 2007